Harvard Bioscience, Inc. (HBIO) Improves Q3 EPS to 8c Amid Lower Sales
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $3.70 -6.8%
EPS Growth %: -16.7%
Financial Fact:
Interest income: 1K
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: -16.7%
Financial Fact:
Interest income: 1K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Harvard Bioscience, Inc. (NASDAQ: HBIO) reported Q3 EPS of $0.08, versus $0.07 reported last year. Revenue for the quarter came in at $26.1 million, versus $26.4 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
For earnings history and earnings-related data on Harvard Bioscience, Inc. (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Synovus Financial (SNV) PT Lowered to $42 at Piper Sandler
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
